Skip to main content

Treatment of Nocturnal Asthma

Buy Article:

$39.50 plus tax (Refund Policy)

Abstract:

Extensive work has been done over the past decade to determine the best drug regimen for the treatment of nocturnal asthma. Much of the work has been directed at the evaluation of theophylline preparations and  sympathomimetic agents. With a better understanding of the mechanisms causing nocturnal asthma, future therapeutic advances will be targeted at the underlying pathophysiological causes of the disorder. This article wilt review current treatment modalities, including those shown to have some effect as welt as those that have no benefit.

Document Type: Research Article

DOI: https://doi.org/10.2500/108854193778816798

Publication date: 1993-01-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • www.AJRA.com
  • www.AllergyandRhinology.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more